ARCHITECT Galectin-3 test regulatory update

BG Medicine disclosed in its 2012 earnings that partner Fujirebio Inc. (Tokyo, Japan) withdrew a 510(k) application for the ARCHITECT

Read the full 206 word article

User Sign In